Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cinobufacini + R-CHOP/CHOP in DLBCL
NCT02871869Phase 3Unknown
- Sponsor
- Xinjiang Medical University
- Start
- Sep 2016
- Primary completion
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cinobufacini in diffuse large B-cell lymphoma (DLBCL), sponsored by Xinjiang Medical University. Status: unknown.
02
Drugs
cinobufacini
03
Conditions
diffuse large B-cell lymphoma (DLBCL)
Beyond the preview
Go deeper on NCT02871869.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02871869.